Add BrightSurf on Google Email

Mount Sinai researchers identify molecular glues that protect insulin-producing cells from damage related to diabetes

Researchers have discovered a novel approach to protecting insulin-producing beta cells from glucolipotoxicity, a condition linked to type 2 diabetes progression. The findings could lead to promising treatments targeting beta cell dysfunction, potentially slowing or preventing disease progression.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNature Communications·TypeExperimental study·DateMar 4, 2025

We feed gut microbes sugar, they make a compound we need

Researchers at Kobe University discovered that gut microbes convert glucose into short-chain fatty acids when fed sugar, highlighting a new symbiotic relationship. This finding could lead to the development of novel therapeutics for regulating gut microbiota and their metabolites.

SourceKobe University·JournalCommunications Medicine·TypeExperimental study·DateMar 3, 2025

Guidelines needed for interpreting continuous glucose monitoring reports in those without diabetes

A new study found high discordance among clinical experts on interpreting CGM reports from individuals without diabetes, highlighting the need for more research and guidelines. Experts recommend follow-up and specific reasoning for their decisions, despite having extensive CGM experience.

SourceBoston University School of Medicine·JournalJournal of Diabetes Science and Technology·TypeSurvey·DateFeb 18, 2025

Mouse study finds impaired cell development: Intermittent fasting could be unsafe for teenagers

A recent study reveals that intermittent fasting can impair beta-cell function and maturation in young mice, potentially leading to diabetes. Researchers found that adolescent mice showed a decline in insulin production after prolonged fasting, with defective beta cells resembling those of type 1 diabetes patients.

SourceTechnical University of Munich (TUM)·JournalCell Reports·TypeExperimental study·DateFeb 14, 2025

Poor vascular health accelerates brain ageing

Researchers at Karolinska Institutet used AI to analyze brain images from 70-year-olds and found that factors like inflammation and high glucose levels are associated with an older-looking brain. A healthy lifestyle, on the other hand, was linked to brains with a younger appearance.

SourceKarolinska Institutet·JournalAlzheimer s & Dementia·TypeObservational study·DateDec 20, 2024

What is metformin’s secret sauce?

A new Northwestern Medicine study reveals how metformin lowers glucose levels by targeting mitochondrial complex I in cells. The drug also improves COVID outcomes and reduces inflammation, suggesting that mitochondrial complex I inhibition may be a unifying mechanism behind its diverse effects.

SourceNorthwestern University·JournalScience Advances·DateDec 18, 2024

Early adoption of sodium-glucose cotransporter-2 inhibitor in patients hospitalized with heart failure with mildly reduced or preserved ejection fraction

Prescription rates of sodium-glucose cotransporter-2 inhibitors increased substantially within 2 years after publication of clinical trial evidence documenting benefit. The study highlights the need to understand strategies used by higher prescribing centers to increase SGLT2i adoption.

SourceJAMA Network·JournalJAMA Cardiology·DateNov 18, 2024

POSTECH team pioneers new cancer therapy strategy: targeting GLUT3 in regulatory T cells to supercharge anti-tumor immunity

Researchers at POSTECH have identified GLUT3 as essential for the suppressive function of regulatory T cells in tumor microenvironments, which can be targeted for cancer immunotherapy. The team's findings highlight the critical role of GLUT3 in regulating protein modifications that sustain immune suppression within tumors.

SourcePohang University of Science & Technology (POSTECH)·JournalCellular and Molecular Immunology·DateNov 12, 2024

Time-restricted eating associated with greater blood sugar control and fat loss than standard nutrition counseling

A randomized controlled trial found that time-restricted eating (TRE) led to greater improvements in glucose control, weight loss, and fat reduction compared to standard nutrition counseling in adults with metabolic syndrome. TRE resulted in a lower risk of muscle mass loss during weight loss.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateSep 30, 2024

Upcycling e-waste into heterogeneous CuxO nano skeletons for high-performance glucose sensing

Scientists at Shanghai Jiao Tong University created a novel glucose sensing system using heterogeneous CuxO nano skeletons from electronic waste. The method employed laser-induced transfer techniques to fabricate electrodes with high sensitivity and stability, achieving detection limits of 0.34 μM.

SourceShanghai Jiao Tong University Journal Center·JournalNano-Micro Letters·TypeExperimental study·DateSep 17, 2024

Researchers present ranges of normal glucose levels among non-diabetic adults wearing continuous glucose monitors

Non-diabetic adults who use continuous glucose monitoring sensors spend significantly more time with elevated glucose levels than previously thought. The study found that normoglycemic participants experienced glucose levels above 140mg/dL for an average of three hours per day.

SourceBoston University School of Medicine·JournalThe Journal of Clinical Endocrinology & Metabolism·TypeData/statistical analysis·DateSep 17, 2024

Cleveland Clinic study adds to increasing evidence that sugar substitute erythritol raises cardiovascular risk

A new study by the Cleveland Clinic found that consuming foods with erythritol increases the risk of cardiovascular events such as heart attack and stroke. The artificial sweetener makes platelets more active, which can raise blood clot risks. This research adds to evidence that erythritol may not be as safe as previously thought.

SourceCleveland Clinic·JournalArteriosclerosis Thrombosis and Vascular Biology·DateAug 8, 2024

Higher glucose levels worsen prognosis in ischemic stroke patients

A study published in Cardiovascular Diabetology found that higher blood glucose levels at admission significantly increase the risk of a poor functional prognosis or death within three months of an ischemic stroke. The study revealed that even a 10% increase in glucose levels raises the risk by 7%, and mortality risk by 88%.

SourceIMIM (Hospital del Mar Medical Research Institute)·JournalCardiovascular Diabetology·DateAug 7, 2024

Ketogenic Diet reduces friendly gut bacteria and raises cholesterol levels - University of Bath study

A new study published in Cell Reports Medicine found that a ketogenic diet can reduce beneficial gut bacteria and increase unfavorable fats in the blood. The diet, which is high in fat and low in carbohydrates, may have long-term health implications such as increased risk of heart disease and stroke.

SourceUniversity of Bath·JournalCell Reports Medicine·TypeRandomized controlled/clinical trial·DateAug 6, 2024

Metformin and other antidiabetic drugs can help reduce the risk of dementia in patients with type 2 diabetes

Researchers analyzed over 1.5 million patient records to find that metformin and SGLT-2 inhibitors lowered dementia and Alzheimer's disease risks compared to other antidiabetic drugs. The study suggests individualized treatment approaches considering patient-specific factors for optimal diabetes management.

SourceElsevier·JournalAmerican Journal of Preventive Medicine·TypeMeta-analysis·DateJul 11, 2024

Combining popular diabetes drugs offers complementary heart and kidney benefits

Researchers found that combining sodium glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists reduces the risk of major adverse cardiovascular events and chronic kidney disease progression by 11% and 33%, respectively. The study suggests using this combination to further improve outcomes in patients with typ...

SourceGeorge Institute for Global Health·JournalThe Lancet Diabetes & Endocrinology·TypeMeta-analysis·DateJul 8, 2024

Proteins and fats can drive insulin production for some, paving way for tailored nutrition

Researchers found that individual responses to proteins and fats can drive insulin production, challenging the long-held belief that fats have negligible effects on insulin release. This study has implications for tailored dietary guidance to manage blood sugar and insulin levels in individuals with diabetes or those at risk.

SourceUniversity of British Columbia·JournalCell Metabolism·TypeObservational study·DateJul 2, 2024

Unveiling secrets of aging beta cells and their ability to secrete insulin

Aging human pancreatic beta cells display features of senescence but maintain elevated levels of genes crucial for function and exhibit an ability to release insulin in response to glucose. This sheds light on the potential role of aging beta cells in immune regulation and their relevance to autoimmune reactions in type 1 diabetes.

SourceThe Hebrew University of Jerusalem·JournalNucleic Acids Research·TypeExperimental study·DateJun 3, 2024